The largest database of trusted experimental protocols

X vivo 15 hematopoietic cell medium

Manufactured by Lonza
Sourced in Switzerland

X-VIVO 15 is a serum-free, chemically defined medium designed for the culture and expansion of hematopoietic cells, including human and animal cells. It is optimized to support the growth and differentiation of hematopoietic progenitor cells.

Automatically generated - may contain errors

2 protocols using x vivo 15 hematopoietic cell medium

1

Isolation and Purification of Intestinal CD4+ TRM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lamina propria mononuclear cells (LPMCs) were isolated from intestinal resection samples as previously described.64 (link) The dead cell removal kit (#130-090-101, Miltenyi Biotec) was used to remove dead cells from LPMCs. The magnetic-activated cell sorting and fluorescence-activated cell sorting were used to obtain pure cell populations. CD4+ TRM cells were isolated from the LPMCs by negative selection using human CD4+ T-cell memory effector cell isolation kit23 (link) (#130-094-125, Miltenyi Biotec). In brief, the magnetically labeled B cells, naive T cells, antigen-presenting cells, CD8+ T cells, non-αβ+ T cells, and effector and central memory CD4+ T cells were positively selected. Then, CD4+ TRM cells in LPMCs were purified using fluorescence-activated cell sorter according to established surface markers CD69 and CD103 (FITC anti-human CD69 antibody, BioLegend 310904; PE/cyanine7 anti-human CD103 antibody, BioLegend 350212).22 (link) For the ex vivo culture of purified CD4+ TRM cells, complete X-VIVO 15 hematopoietic cell medium was obtained from Lonza (#BE02-060Q).
+ Open protocol
+ Expand
2

Bladder Cancer Cell Lines Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines, reagents and chemicals. T24 human bladder carcinoma (BCRC No.60062) and BFTC905 human bladder papillary transitional cell carcinoma (BCRC No.60068) cell lines were purchased from Bioresources Collection and Research Center (Hsin Chu City, Taiwan, ROC). Ficoll ® Paque Plus was purchased from GE Healthcare Life Sciences (Parramatta NSW, Australia). Carboplatin was purchased from Accela ChemBio. Inc. (San Diego, CA, USA). X-VIVO 15 hematopoietic cell medium was bought from Lonza (Basel, Switzerland). Human recombinant IL2 (Proleukin ® ) was purchased from Novartis (Taipei, Taiwan, ROC). Zoledronic acid (ZometaTM) was purchased from Yungshin Pharm Ind. Co. Ltd. (Taipei, Taiwan, ROC). Alamar Blue™ Cell Viability Reagent, McCoy's 5a (for T24 cells), RPMI 1640 (for BFTC 905 cells), Lglutamate, fetal bovine serum and TrypLE Express Enzyme solution were bought from Gibco (ThermoFisher Scientific Inc., Waltham, MA, USA). Human monoclonal antibody isotype fluorescein isothiocyanate (FITC)-conjugated IgG1, peridinin-hlorophyll-protein (PerCP)-conjugated IgG1, allophycocyanin (APC)-conjugated IgG1, CD3-PerCP, brilliant violet (BV) 421-conjugated TCRγδ, APCconjugated natural killer group 2 member D (NKG2D), CD27-FITC, R-phyco-erythrin (PE)-cyanine 7 (Cy7)-conjugated CD45RA were all purchased from BD Biosciences (San Jose, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!